Aequus Pharmaceuticals (TSX-V: AQS) is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus' management team has a proven track record of managing clinical development, regulatory approval, product launches, and marketing products either directly or through partnerships.

Aequus' commercial pipeline is focused on highly specialized therapeutic areas, including neurology, ophthalmology and transplant. The development stage pipeline includes several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems.

Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.

Through the recent acquisition of TeOra Health, we have a commercial platform to build on for the launch of additional products that are either created internally or brought in through an acquisition or license.